@article{e945ba5d02d345ecb0100329f54fdf49,
title = "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines",
keywords = "ACC/AHA Clinical Practice Guidelines, Guidelines, LDL-cholesterol, biomarkers, cardiovascular disease, cholesterol, coronary artery calcium score, diabetes mellitus, drug therapy, ezetimibe, hydroxymethylglutaryl-CoA reductase inhibitors/statins, hypercholesterolemia, lipids, patient compliance, pharmacological, primary prevention, proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors, risk assessment, risk reduction discussion, risk treatment discussion, secondary prevention",
author = "Grundy, \{Scott M.\} and Stone, \{Neil J.\} and Bailey, \{Alison L.\} and Craig Beam and Birtcher, \{Kim K.\} and Blumenthal, \{Roger S.\} and Braun, \{Lynne T.\} and \{de Ferranti\}, Sarah and Joseph Faiella-Tommasino and Forman, \{Daniel E.\} and Ronald Goldberg and Heidenreich, \{Paul A.\} and Hlatky, \{Mark A.\} and Jones, \{Daniel W.\} and Donald Lloyd-Jones and Nuria Lopez-Pajares and Ndumele, \{Chiadi E.\} and Orringer, \{Carl E.\} and Peralta, \{Carmen A.\} and Saseen, \{Joseph J.\} and Smith, \{Sidney C.\} and Laurence Sperling and Virani, \{Salim S.\} and Joseph Yeboah",
year = "2019",
month = jun,
day = "25",
doi = "10.1016/j.jacc.2018.11.002",
language = "English (US)",
volume = "73",
pages = "3168--3209",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier Inc.",
number = "24",
}